Pharmacologic, Pharmacodynamic, and Pharmacokinetic Considerations with Intravenous Ibuprofen Lysine

par Capparelli, Edmund V.
Publié 2007

Nitazoxanide Treatment of Cryptosporidium parvum in Human Immunodeficiency Virus-Infected Children

par Capparelli, Edmund V., Syed, Salma S.
Publié 2008

Implications of gender and pregnancy for antiretroviral drug dosing

par Best, Brookie M., Capparelli, Edmund V.
Publié 2008

Population pharmacokinetics of siltuximab: Impact of disease state

par Nikanjam, Mina, Yang, Jin, Capparelli, Edmund V.
Publié dans Cancer Chemother Pharmacol (2019)

Association of concurrent acid-suppression therapy with survival outcomes and adverse event incidence in oncology patients receiving erlotinib

par Lam, Lisa H., Capparelli, Edmund V., Kurzrock, Razelle
Publié dans Cancer Chemother Pharmacol (2016)

High Dose of Darunavir in Treatment-experienced HIV-infected Adolescent Results in Virologic Suppression and Improved CD4 Count

par Rakhmanina, Natella Y., Neely, Michael N., Capparelli, Edmund V.
Publié 2012

Determination of Efavirenz in Human Dried Blood Spots by Reversed-Phase High Performance Liquid Chromatography with UV Detection

par Hoffman, Justin T, Rossi, Steven S, Espina-Quinto, Rowena, Letendre, Scott, Capparelli, Edmund V
Publié 2013

Persistent Cytarabine and Daunorubicin Exposure after administration of Novel Liposomal Formulation CPX-351: Population Pharmacokinetic Assessment

par Nikanjam, Mina, Capparelli, Edmund V., Lancet, Jeffrey E., Louie, Arthur, Schiller, Gary
Publié dans Cancer Chemother Pharmacol (2017)

Pharmacokinetics of a Fluoronaphthyridone, Trovafloxacin (CP 99,219), in Infants and Children following Administration of a Single Intravenous Dose of Alatrofloxacin

par Bradley, John S., Kearns, Gregory L., Reed, Michael D., Capparelli, Edmund V., Vincent, John
Publié 2000

Indinavir Population Pharmacokinetics in Plasma and Cerebrospinal Fluid

par Letendre, Scott L., Capparelli, Edmund V., Ellis, Ronald J., McCutchan, J. Allen
Publié 2000

Pharmacokinetics and Pharmacodynamics of Antifungals in Children: Clinical Implications

par Autmizguine, Julie, Guptill, Jeffrey T., Cohen-Wolkowiez, Michael, Benjamin, Daniel K., Capparelli, Edmund V.
Publié 2014

Optimizing Pediatric Esmolol Dosing Using Computerized Practitioner Order Entry

par Chao, Tihua, Perry, James C., Romanowski, Gale L., Tremoulet, Adriana H., Capparelli, Edmund V.
Publié dans J Pediatr Pharmacol Ther (2014)

Acetaminophen Pharmacokinetics in Children with Nonalcoholic Fatty Liver Disease

par Barshop, Nicole J., Capparelli, Edmund V., Sirlin, Claude B., Schwimmer, Jeffrey B., Lavine, Joel E
Publié 2011

Phase I Clinical Trial Results of Auranofin, a Novel Antiparasitic Agent

par Capparelli, Edmund V., Bricker-Ford, Robin, Rogers, M. John, McKerrow, James H., Reed, Sharon L.
Publié dans Antimicrob Agents Chemother (2016)

Population Pharmacokinetics of Abacavir in Plasma and Cerebrospinal Fluid

par Capparelli, Edmund V., Letendre, Scott L., Ellis, Ronald J., Patel, Parul, Holland, Diane, McCutchan, J. Allen
Publié 2005

Population Pharmacokinetic Assessment and Pharmacodynamic Implications of Pediatric Cefepime Dosing for Susceptible-Dose-Dependent Organisms

par Shoji, Kensuke, Bradley, John S., Reed, Michael D., van den Anker, John N., Domonoske, Christine, Capparelli, Edmund V.
Publié dans Antimicrob Agents Chemother (2016)

Population Pharmacokinetics and Exploratory Pharmacodynamics of Lorazepam in Pediatric Status Epilepticus

par Gonzalez, Daniel, Chamberlain, James M., Guptill, Jeffrey T., Cohen-Wolkowiez, Michael, Harper, Barrie, Zhao, Jian, Capparelli, Edmund V.
Publié dans Clin Pharmacokinet (2017)

Vincristine Associated Neuropathy with Antifungal Usage: A Kaiser Northern California Experience

par Nikanjam, Mina, Sun, Aida, Albers, Mark, Mangalindin, Kristine, Song, Eyun, Vempaty, Hyma, Sam, Danny, Capparelli, Edmund V.
Publié dans J Pediatr Hematol Oncol (2018)

Developmental Pharmacokinetic Changes of Lamivudine in Infants and Children

par Tremoulet, Adriana H., Nikanjam, Mina, Cressey, Tim R., Chokephaibulkit, Kulkanya, McKinney, Ross, Mirochnick, Mark, Capparelli, Edmund V.
Publié 2011

Population pharmacokinetic analysis of oxaliplatin in adults and children identifies important covariates for dosing

par Nikanjam, Mina, Stewart, Clinton F., Takimoto, Chris H., Synold, Timothy W., Beaty, Orren, Fouladi, Maryam, Capparelli, Edmund V.
Publié dans Cancer Chemother Pharmacol (2015)